Setsuko Komuro

629 total citations
34 papers, 511 citations indexed

About

Setsuko Komuro is a scholar working on Pharmacology, Oncology and Biochemistry. According to data from OpenAlex, Setsuko Komuro has authored 34 papers receiving a total of 511 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pharmacology, 15 papers in Oncology and 6 papers in Biochemistry. Recurrent topics in Setsuko Komuro's work include Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (13 papers) and Vitamin D Research Studies (4 papers). Setsuko Komuro is often cited by papers focused on Pharmacogenetics and Drug Metabolism (15 papers), Drug Transport and Resistance Mechanisms (13 papers) and Vitamin D Research Studies (4 papers). Setsuko Komuro collaborates with scholars based in Japan and United States. Setsuko Komuro's co-authors include Masashi Yabuki, Takanori Hashizume, Masashi Mise, Toru Usui, Kimihiko Sato, Atsushi Kitamura, Iwao Nakatsuka, Hiroshi Kanamaru, H Kanamaru and Akira Yoshitake and has published in prestigious journals such as Analytical and Bioanalytical Chemistry, Biomedicine & Pharmacotherapy and Drug Metabolism and Disposition.

In The Last Decade

Setsuko Komuro

33 papers receiving 487 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Setsuko Komuro Japan 13 226 194 134 62 58 34 511
Hiromitsu Nakasa Japan 13 333 1.5× 210 1.1× 137 1.0× 111 1.8× 39 0.7× 30 596
Soraya Madani United States 6 291 1.3× 153 0.8× 86 0.6× 38 0.6× 109 1.9× 8 534
Yoshihiko Funae Japan 15 456 2.0× 212 1.1× 179 1.3× 89 1.4× 43 0.7× 21 812
Su-Er W. Huskey United States 11 194 0.9× 127 0.7× 133 1.0× 56 0.9× 17 0.3× 13 548
Punit H. Marathe United States 15 158 0.7× 220 1.1× 246 1.8× 96 1.5× 21 0.4× 31 854
Yasuhiro Masubuchi Japan 16 598 2.6× 242 1.2× 153 1.1× 55 0.9× 34 0.6× 29 902
Claire Belloc France 13 519 2.3× 197 1.0× 225 1.7× 65 1.0× 46 0.8× 15 789
H. Noguchi Japan 15 223 1.0× 196 1.0× 211 1.6× 49 0.8× 29 0.5× 58 641
Tsutomu Yoshimura Japan 13 171 0.8× 183 0.9× 205 1.5× 88 1.4× 16 0.3× 28 594
Ryan Takahashi United States 13 189 0.8× 129 0.7× 173 1.3× 58 0.9× 21 0.4× 31 443

Countries citing papers authored by Setsuko Komuro

Since Specialization
Citations

This map shows the geographic impact of Setsuko Komuro's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Setsuko Komuro with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Setsuko Komuro more than expected).

Fields of papers citing papers by Setsuko Komuro

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Setsuko Komuro. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Setsuko Komuro. The network helps show where Setsuko Komuro may publish in the future.

Co-authorship network of co-authors of Setsuko Komuro

This figure shows the co-authorship network connecting the top 25 collaborators of Setsuko Komuro. A scholar is included among the top collaborators of Setsuko Komuro based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Setsuko Komuro. Setsuko Komuro is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Usui, Toru, Takanori Hashizume, Takashi Katsumata, Tsuyoshi Yokoi, & Setsuko Komuro. (2011). In Vitro Investigation of the Glutathione Transferase M1 and T1 Null Genotypes as Risk Factors for Troglitazone-Induced Liver Injury. Drug Metabolism and Disposition. 39(7). 1303–1310. 11 indexed citations
2.
Sato, Kimihiko, et al.. (2011). Prediction of the Intestinal First-pass Metabolism of CYP3A and UGT Substrates in Humans from in vitro Data. Drug Metabolism and Pharmacokinetics. 26(6). 592–601. 49 indexed citations
3.
Sato, Kimihiko, et al.. (2011). Species Differences in Intestinal Metabolic Activities of Cytochrome P450 isoforms between Cynomolgus Monkeys and Humans. Drug Metabolism and Pharmacokinetics. 26(3). 300–306. 24 indexed citations
4.
Kitamura, Atsushi, et al.. (2011). Liver uptake of Biguanides in rats. Biomedicine & Pharmacotherapy. 65(6). 451–455. 9 indexed citations
5.
Sato, Kimihiko, et al.. (2010). Prediction of the Intestinal First-Pass Metabolism of CYP3A Substrates in Humans Using Cynomolgus Monkeys. Drug Metabolism and Disposition. 38(11). 1967–1975. 26 indexed citations
6.
Kitamura, Atsushi, et al.. (2009). A comparison of uptake of metformin and phenformin mediated by hOCT1 in human hepatocytes. Biopharmaceutics & Drug Disposition. 30(8). 476–484. 47 indexed citations
7.
Nishizato, Yohei, et al.. (2009). Development of relevant assay system to identify steroidogenic enzyme inhibitors. Toxicology in Vitro. 24(2). 677–685. 5 indexed citations
8.
Usui, Toru, Masashi Mise, Takanori Hashizume, Masashi Yabuki, & Setsuko Komuro. (2009). Evaluation of the Potential for Drug-Induced Liver Injury Based on in Vitro Covalent Binding to Human Liver Proteins. Drug Metabolism and Disposition. 37(12). 2383–2392. 122 indexed citations
9.
Mise, Masashi, Takanori Hashizume, & Setsuko Komuro. (2008). Characterization of Substrate Specificity of Dog CYP1A2 Using CYP1A2-Deficient and Wild-Type Dog Liver Microsomes. Drug Metabolism and Disposition. 36(9). 1903–1908. 22 indexed citations
10.
Mizuno, Yoshiko, et al.. (2007). Identification of CYP3A4 as the primary cytochrome P450 responsible for the metabolism of tandospirone by human liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics. 32(4). 233–240. 7 indexed citations
11.
12.
Yabuki, Masashi, et al.. (2005). Characterization of the enzymes involved in thein vitrometabolism of amrubicin hydrochloride. Xenobiotica. 35(12). 1121–1133. 27 indexed citations
13.
Kitamura, Atsushi, et al.. (2004). Characterization of human cytochrome P450 enzymes involved in thein vitro metabolism of perospirone. Biopharmaceutics & Drug Disposition. 26(2). 59–65. 11 indexed citations
14.
Komuro, Setsuko, Masayuki Sato, & Hiroshi Kanamaru. (2003). DISPOSITION AND METABOLISM OF F6-1α,25(OH)2 VITAMIN D3 AND 1α,25(OH)2 VITAMIN D3 IN THE PARATHYROID GLANDS OF RATS DOSED WITH TRITIUM-LABELED COMPOUNDS. Drug Metabolism and Disposition. 31(8). 973–978. 8 indexed citations
15.
Shimakura, Jin, et al.. (2003). In vitro drug-drug interactions with perospirone and concomitantly administered drugs in human liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics. 28(1). 67–72. 4 indexed citations
16.
Mizuno, Yoshiko, et al.. (2003). In vitro metabolism of perospirone in rat, monkey and human liver microsomes. European Journal of Drug Metabolism and Pharmacokinetics. 28(1). 59–65. 15 indexed citations
17.
Shimakura, Jin, Keiichi Fujimoto, Setsuko Komuro, Minoru Nakano, & H Kanamaru. (2002). Long-term disposition of a novel lipophilic platinum complex SM-11355 in dog after intrahepatic arterial administration: highly sensitive detection of platinum and radioactivity. Xenobiotica. 32(5). 399–409. 9 indexed citations
18.
19.
Komuro, Setsuko, Hiroshi Kanamaru, Iwao Nakatsuka, & Akira Yoshitake. (1998). Distribution and metabolism of F 6 -1,25(OH) 2 Vitamin D 3 and 1,25(OH) 2 Vitamin D 3 in the bones of rats dosed with tritium-labeled compounds. Steroids. 63(10). 505–510. 11 indexed citations
20.
Komuro, Setsuko, et al.. (1994). Quantitative determination of F6-1,25(OH)2 vitamin D3 in human serum by gas chromatography/mass spectrometry with high-resolution selected ion monitoring. Journal of Mass Spectrometry. 23(1). 33–38. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hiromitsu Nakasa Breakdown of academic impact, for papers by Soraya Madani Breakdown of academic impact, for papers by Yoshihiko Funae Breakdown of academic impact, for papers by Su-Er W. Huskey Breakdown of academic impact, for papers by Punit H. Marathe Breakdown of academic impact, for papers by Yasuhiro Masubuchi Breakdown of academic impact, for papers by Claire Belloc Breakdown of academic impact, for papers by H. Noguchi Breakdown of academic impact, for papers by Tsutomu Yoshimura Breakdown of academic impact, for papers by Ryan Takahashi
Rankless by CCL
2026